Midkine—A novel player in cardiovascular diseases
Midkine (MK) is a 13-kDa heparin-binding cytokine and growth factor with anti-apoptotic, pro-angiogenic, pro-inflammatory and anti-infective functions, that enable it to partake in a series of physiological and pathophysiological processes. In the past, research revolving around MK has concentrated...
Main Authors: | Marina Majaj, Ludwig T. Weckbach |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.1003104/full |
Similar Items
-
The role of midkine in health and disease
by: Emely Elisa Neumaier, et al.
Published: (2023-11-01) -
Association between serum midkine levels and tumor size in Indonesian hepatocellular carcinoma patients: a cross-sectional study
by: Darmadi Darmadi, et al.
Published: (2022-12-01) -
Expression of copeptin and midkine in diabetic retinopathy and their significance
by: Jian-Dan Ren, et al.
Published: (2018-11-01) -
Midkine’s Role in Cardiac Pathology
by: Kathleen C. Woulfe, et al.
Published: (2017-08-01) -
The circulating midkine in the newly diagnosed celiac disease: Clinical implications
by: Mohammad Hassan Emami, et al.
Published: (2021-01-01)